MD Anderson and Varian announce strategic collaboration to optimize radiation oncology treatment

NewsGuard 100/100 Score

The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.

The goal of the platform is to establish an efficient framework to connect participating sites to a central database, allowing MD Anderson physicians to host collaborative review sessions around treatment plans and to communicate plan changes back to physicians. As the platform matures, it has the potential to be deployed at all MD Anderson locations and across MD Anderson Cancer Network®.

Radiation oncology is a highly technical specialty that relies on the interoperability of a variety of hardware and software components. We believe the development of this unified platform with Varian will enable expansion of our radiation oncology quality standards to provide the best available care to more patients."

Albert Koong, M.D., Ph.D., professor and division head of Radiation Oncology, MD Anderson

MD Anderson Cancer Network, a program of MD Anderson Cancer Center, collaborates with community hospitals and health care systems around the globe to provide higher quality and advanced care to patients in the communities in which they live.

In addition to the software platform, the partnership will work to develop evidence-based tools to improve the analysis of various quality measures, with a focus on:

-Minimizing the volume of radiation dose distributed to nearby healthy organs, resulting in fewer side effects for patients

-Automating the comparison of treatment plans to MD Anderson and national quality criteria, enabling the development of new standard value and safety metrics

-Decreasing the time needed to review radiation treatment plans, improving efficiency and expanding access

"We are honored to work with MD Anderson on developing a new software platform that helps ensure patients across the MD Anderson Cancer Network receive a higher standard of care regardless of location," said Corey Zankowski, senior vice president, Oncology Software Solutions, Varian. "Innovative partnerships like this will help us achieve our vision of a world without fear of cancer."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LungVax vaccine uses DNA technology to prevent lung cancer